These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15994922)

  • 1. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
    Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
    J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
    Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
    Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC.
    Hnátková M; Mociková H; Trnený M; Zivný J
    Prague Med Rep; 2009; 110(1):35-41. PubMed ID: 19591376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
    Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
    J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
    Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases.
    Echigo T; Hasegawa M; Shimada Y; Inaoki M; Takehara K; Sato S
    Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
    Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
    Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS).
    Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J
    Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.
    Farina L; Rezzonico F; Spina F; Dodero A; Mazzocchi A; Crippa F; Alessi A; Dalto S; Viviani S; Corradini P
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):1982-8. PubMed ID: 25240818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma].
    Raida L; Papajík T; Hlusí A; Faber E; Urbanová R; Heczko M; Jancíková M; Zapletalová J; Komenda S; Indrák K
    Vnitr Lek; 2002 Feb; 48(2):91-5. PubMed ID: 11949228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
    Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
    Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
    Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
    Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
    J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma.
    Tecchio C; Nadali G; Scapini P; Bonetto C; Visco C; Tamassia N; Vassilakopoulos TP; Pangalis GA; Calzetti F; Nardelli B; Roschke V; Gottardi M; Zampieri F; Gherlinzoni F; Facchetti F; Pizzolo G; Cassatella MA
    Br J Haematol; 2007 Jun; 137(6):553-9. PubMed ID: 17539776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.
    Casasnovas RO; Mounier N; Brice P; Divine M; Morschhauser F; Gabarre J; Blay JY; Voillat L; Lederlin P; Stamatoullas A; Bienvenu J; Guiguet M; Intrator L; Grandjean M; Brière J; Ferme C; Salles G;
    J Clin Oncol; 2007 May; 25(13):1732-40. PubMed ID: 17389336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
    Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
    Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.